0
฿0.00
An empty cart
You have no item in your shopping cart
Product Category · Pharmaceutical Industry
Compressed Air Filterfor Pharmaceutical Industry
Pharmaceutical manufacturing requires a sterile compressed air filtration system designed with multiple filtration stages to ensure consistent air quality and contamination control. Each filtration stage is engineered to remove specific contaminants, from bulk particles and condensed oil to oil vapor and microorganisms. Our GMP-compliant compressed air filtration systems combine particle filtration, coalescing filters, activated carbon filtration, and sterile membrane filters to help achieve ISO 8573-1 Class 0 air quality standards for critical pharmaceutical applications.
✓ ISO 8573-1 Class 0 ✓ 0.01 µm Coalescing ✓ 0.2 µm Sterile Membrane ✓ Integrity Test Certified
System Overview
Key Specifications
Pre-Filter1 µm — bulk particle and liquid water removal
Coalescing0.01 µm — oil aerosol, sub-micron particles
Carbon OVROil vapour reduction to <0.003 mg/m³
Sterile POU0.2 µm membrane — microbial removal
Integrity TestBubble point / Forward flow diffusion
ComplianceEU GMP Annex 1, FDA, WHO GMP, PIC/S
✓ ISO 8573-1 Class 0 ✓ 0.2 µm Sterile Membrane ✓ Integrity Test Documented ✓ IQ/OQ Support ✓ BMS-Integrated Monitoring
Industry Overview
Why a Multi-Stage Pharmaceutical Grade Compressed Air Filter Train Is the GMP Requirement
No single filter can remove all contaminants from compressed air to the level that pharmaceutical GMP requires. A Compressed Air Filter for Pharmaceutical Industry installation must be a correctly sequenced multi-stage train because each contaminant category requires a fundamentally different filtration mechanism. Particulate filters cannot remove dissolved oil vapour. Activated carbon cannot remove liquid water droplets. Membrane sterile filters must not be exposed to oil or liquid water — both of which blind the membrane and cause premature failure. The sequence of each stage is not optional: it is determined by the contamination characteristics of pharmaceutical-grade compressed air and the operating requirements of each filter type.
A correctly designed Pharma Compressed Air Purification System delivers ISO 8573-1 Class 0 at each critical point of use — with each filter stage independently documented, integrity-tested (for sterile filters) and included in the IQ/OQ qualification scope of the overall compressed air utility system. Our High Efficiency Compressed Air Filter for Pharma range is designed specifically for this multi-stage sequential installation — with housing materials, element specifications and documentation packages that match GMP pharmaceutical requirements at every stage.
The combination of an Oil Free Compressed Air Filter Pharmaceutical system downstream of a certified oil-free compressor provides the redundant contamination control that ICH Q9 risk management and EU GMP Annex 1 require — two independent barriers against oil contamination of pharmaceutical compressed air, each documented and monitored.
- Stage 1 — 1 µm pre-filter: bulk particles, liquid water, rust and scale
- Stage 2 — 0.01 µm coalescing: oil aerosol, sub-micron particles
- Stage 3 — Activated carbon OVR: oil vapour to <0.003 mg/m³
- Stage 4 — 0.2 µm sterile membrane: bioaerosols, bacteria, spores at point of use
- Integrity test documentation for each sterile filter — bubble point or forward flow
- IQ/OQ documentation support — every filter stage included in qualification scope
Why It Matters
Three Critical Reasons Filter Stage Sequence & Specification Determine GMP Compliance
01🛡️Sterile Filtration at Point of Use
The Sterile Filter at Point of Use Is the Last Barrier Before the Product
In aseptic pharmaceutical manufacturing, the 0.2 µm sterile membrane filter at the point of use is the final barrier between the compressed air distribution system and the product, primary packaging or Grade A zone. The Contamination Control Compressed Air Filter Pharma at this position must remove bacteria, fungal spores and bioaerosols with a log reduction value ≥ 10⁷ at rated flow conditions. EU GMP Annex 1 §4.33 explicitly requires that compressed air used in sterile environments be sterile-filtered at the point of use — and that the sterile filter be integrity-tested before each use or on a validated scheduled frequency to confirm the membrane is intact.
A sterile filter that fails its integrity test — meaning the bubble point or forward flow result falls outside the validated range — must be replaced before the compressed air supply can be used. Using unvalidated sterile filtration in an aseptic manufacturing environment is a GMP Critical Deficiency.
02🔬Oil Aerosol & Vapour Removal
Oil Contamination at Microgram Levels Causes Product Failure and GMP Findings
Even when an oil-free compressor is used, oil contamination can enter the compressed air system from compressor room air ingestion, lubricants in non-compressor components, and cross-contamination from adjacent oil-lubricated equipment. An ISO 8573 Compressed Air Filter Pharma 0.01 µm coalescing filter removes oil aerosols — liquid oil droplets suspended in the air stream — while the downstream activated carbon Oil Vapour Reduction (OVR) filter adsorbs oil vapour molecules that pass through the coalescing stage. Both stages are required for ISO 8573-1 Class 0 oil compliance: coalescing alone cannot remove vapour-phase oil contamination, and activated carbon alone cannot handle liquid oil droplet loading without rapid saturation.
The coalescing filter must always be installed upstream of the activated carbon OVR filter. Reversing the order — carbon before coalescing — causes rapid carbon bed saturation with liquid oil, requiring premature element replacement and creating a risk of carbon particle downstream contamination.
03📋Validation & Documentation
Every Filter Stage Must Be Validated, Documented and Included in the IQ/OQ Scope
A Cleanroom Compressed Air Filter or sterile filter in pharmaceutical manufacturing is not simply a consumable component — it is part of a GMP-regulated utility system that must be qualified. This means every filter housing, every element type and every change-out procedure must be documented in the Installation Qualification (IQ), operational performance must be verified in the Operational Qualification (OQ), and ongoing performance must be confirmed through scheduled integrity testing, element change records and air quality sampling. The filter change schedule must be based on validated criteria — pressure differential monitoring or time-based, whichever is more conservative — rather than informal observation.
Filter change records, integrity test certificates and air quality test results are GMP documents — they must be retained, subject to change control and available for inspection. A pharmaceutical facility that cannot produce a complete filter maintenance history for its sterile compressed air system will receive a GMP finding at inspection.
Product Range
GMP Compressed Air Filter Systems for Pharmaceutical Manufacturing
Our Pharmaceutical Grade Compressed Air Filter range covers every stage of the pharmaceutical filtration train — from high-capacity coalescing pre-filters through oil vapour reduction to sterile membrane point-of-use filters — with all housings and elements specified for GMP pharmaceutical use.
⭐ Oil & Particle Removal 🔩
Coalescing Filter — 0.01 µm
High-efficiency Contamination Control Compressed Air Filter Pharma — 0.01 µm borosilicate glass fibre coalescing element for oil aerosol and sub-micron particle removal. Glass-reinforced nylon or stainless steel housings. Automatic drain valve. Achieves ISO 8573-1 Class 1 oil aerosol (≤0.01 mg/m³).
Technical Specifications
| Filtration | 0.01 µm coalescing — glass fibre medium |
| Oil Aerosol | ISO 8573-1 Class 1 — ≤0.01 mg/m³ outlet |
| Particle | Class 1 — >99.99% removal at 0.01 µm |
| Housing | GRP or 316L SS — automatic drain as standard |
| ΔP Indicator | Visual differential pressure indicator included |
Applications
Oil Vapour Reduction 🌿
Activated Carbon OVR Filter
Oil Vapour Reduction (OVR) High Efficiency Compressed Air Filter for Pharma — activated carbon adsorption bed reducing residual oil vapour to <0.003 mg/m³ for ISO 8573-1 Class 0 oil compliance. Must be installed downstream of the 0.01 µm coalescing filter — never directly after the compressor or dryer.
Technical Specifications
| Technology | Activated carbon adsorption — high-purity granular |
| Oil Vapour | ISO 8573-1 Class 0 — ≤0.003 mg/m³ outlet |
| Inlet Req. | Dry, oil-aerosol-free air — coalescing pre-filter mandatory |
| Change | Time-based or by breakthrough indicator |
| Housing | GRP or 316L SS — same footprint as coalescing |
Applications
Point of Use — Sterile 🔬
Sterile Membrane Filter — 0.2 µm
Oil Free Compressed Air Filter Pharmaceutical — 0.2 µm PTFE or polyethersulfone (PES) membrane sterile filter for point-of-use installation in Grade A/B cleanrooms. Rated for sterilisation by autoclave or in-line steam. Integrity-tested before use by bubble point or forward flow diffusion method with documented test certificates.
Technical Specifications
| Membrane | 0.2 µm PTFE or PES — hydrophobic for air service |
| Log Reduction | ≥10⁷ LRV — compliant with USP <1229.3> |
| Sterilisation | Autoclave or in-line steam — 134°C / 30 min rated |
| Integrity Test | Bubble point + forward flow — certificate per use |
| Housing | 316L SS electropolished — IQ-compatible certification |
Applications
Why Choose Domnick
Benefits of Our GMP Pharmaceutical Compressed Air Filter Systems
A Pharma Compressed Air Purification System requires correct stage sequencing, material specifications, documentation and integrity testing protocols — not just high-efficiency filter media. We design and supply complete qualified filter trains for pharmaceutical manufacturers throughout Thailand.
01✅
Correct Stage Sequencing
ISO 8573 Compressed Air Filter Pharma system designed with the correct stage sequence — pre-filter, coalescing, activated carbon OVR, sterile membrane — specified in the correct order to protect each downstream stage and achieve Class 0 compliance reliably.
02🔬
Sterile Filter Integrity Testing
Bubble point and forward flow diffusion integrity test equipment, test procedures and test documentation — ensuring every Sterile Compressed Air Filtration System installation has the integrity verification programme GMP Annex 1 requires.
03📋
IQ/OQ Documentation Support
Filter housing specifications, element certificates, flow and pressure calculations, integrity test records and change procedure documentation — all structured to integrate directly into your compressed air utility qualification scope under GMP.
04📡
Differential Pressure Monitoring
ΔP indicators and transmitters on every filter stage with BMS integration — providing the real-time element loading data needed to schedule filter changes before pressure drop causes flow restriction at critical manufacturing points of use.
05🏭
GMP-Grade Housing Materials
Cleanroom Compressed Air Filter housings in glass-reinforced polymer or 316L electropolished stainless steel — no polymer components that could contribute extractables to the filtered air stream, with material certification included in the IQ package.
06🔧
Validated Change-Out Procedures
Element change procedures, torque specifications, post-change integrity test protocols and change record forms — structured to maintain GMP control over every filter element replacement as part of your validated maintenance programme.
Applications
Pharmaceutical Compressed Air Filter Applications in GMP Manufacturing
Filter stage requirements differ by application in pharmaceutical manufacturing — sterile aseptic zones need the full four-stage train including 0.2 µm sterile membrane, while non-sterile manufacturing areas require coalescing and OVR filtration without the sterile stage at every point of use.
💉
Aseptic Sterile Filling
Grade A / B Cleanroom
Full 4-stage filter train — pre-filter, 0.01 µm coalescing, activated carbon OVR and 0.2 µm sterile membrane at point of use. Sterile filter integrity-tested before each use. Required for vial, ampoule and syringe filling in aseptic environments
EU GMP Annex 1 · USP <1229.3>💊
Tablet Coating & Solid Dose
Solid Dosage Manufacturing
Pre-filter + 0.01 µm coalescing + activated carbon OVR for tablet coating atomisation air — oil contamination in coating air affects film uniformity and drug release. Sterile 0.2 µm at final spray gun connection where air contacts tablet cores directly
EU GMP Part I · ISO 8573-1❄️
Lyophilization
Sterile Biopharmaceuticals
0.2 µm sterile membrane filter on lyophilizer chamber vent line and stopper mechanism air supply — prevents bioaerosol ingress during chamber door opening and sterile venting cycles. Integrity-tested before each lyophilization cycle per validated protocol
EU GMP Annex 1 · PIC/S⚗️
API Synthesis
Active Pharmaceutical Ingredient
Coalescing + OVR filter train for API reactor aeration and fermentation air supply — oil contamination in API aeration air can react with chemical intermediates and affect API yield and purity. ICH Q7 clean utility requirements apply to all API process air
ICH Q7 · EU GMP Part II🏭
Cleanroom & HVAC
Facility Utilities
Pre-filter + coalescing for cleanroom HVAC pneumatic controls, damper actuators and instrument air — lower criticality than product-contact applications but still must be demonstrably clean. Sterile membrane at HVAC air ingress points in Grade A/B zones
ISO 14644 · EU GMP Vol. 4🔬
Laboratory & QC
Quality Control
Coalescing + OVR filter train for analytical instrument air, dissolution testing equipment and general QC laboratory compressed air supply — ISO 8573-1 Class 1 minimum for instrument air; Class 0 where air contacts samples or reference standards directly
ISO 8573-1 · ASTM D1193 Filtration Technology Guide
Filter Train Design, Sterile Integrity Testing & Microbial Monitoring for Pharmaceutical Compressed Air
Understanding why each stage of the Compressed Air Filter for Pharmaceutical Industry train is necessary — and what happens when a stage is missing, mis-sequenced or not maintained — is the foundation of a correctly designed and GMP-compliant compressed air filtration system. This guide covers stage design principles, sterile filter integrity testing methodology, and the microbial monitoring programme that GMP Annex 1 requires for compressed air in pharmaceutical manufacturing environments.
Pharmaceutical Compressed Air — Filter Train Stage Sequence & Function
1 Stage 01 · Entry
Pre-Filter
ISO 8573-1 · Class 3 particle
Removes
- Bulk solid particles ≥1 µm
- Liquid water droplets
- Rust and scale fragments
- Protects coalescing stage
2 Stage 02 · Oil Aerosol
Coalescing
ISO 8573-1 · Class 1 oil aerosol
Removes
- Oil aerosol droplets ≥0.01 µm
- Sub-micron particles
- Residual liquid — to ≤0.01 mg/m³
- Must precede carbon OVR stage
3 Stage 03 · Oil Vapour
Activated Carbon OVR
ISO 8573-1 · Class 0 oil (<0.003 mg/m³)
Removes
- Oil vapour molecules (gaseous phase)
- Organic odours and hydrocarbons
- Residual VOC contamination
- Inlet must be dry + aerosol-free
4 Stage 04 · Point of Use
Sterile Membrane
0.2 µm · LRV ≥10⁷ · Integrity Tested
Removes
- Bacteria and fungal spores
- Bioaerosols and mycoplasma
- Integrity tested every use cycle
- Installed at each POU in Grade A/B
Sterile Filter Integrity Testing — Two Validated Methods
EU GMP Annex 1 and USP <1229.3> require that every sterile membrane filter used in pharmaceutical compressed air be integrity-tested to confirm that the membrane is intact and capable of the claimed microbial log reduction performance. There are two validated integrity test methods — both are accepted by GMP inspectors and both produce quantitative pass/fail results that must be documented and retained as GMP records.
Method A — Primary Test
Bubble Point Test
ASTM F316 · USP <1229.3> · EU GMP Annex 1
The bubble point test measures the minimum pressure required to force the largest pores of the wetted membrane open sufficiently to allow gas passage. The membrane is wetted with water (or appropriate wetting fluid), and gas pressure is increased gradually on the upstream side while the downstream side is observed for continuous bubble flow. The pressure at which a continuous stream of bubbles first appears is the bubble point pressure.
Pass criterion: The measured bubble point pressure must be ≥ the minimum bubble point specified by the filter manufacturer for that membrane type, pore size and wetting fluid — verified by correlation with the validated microbial retention test data for that filter. A bubble point below specification indicates a membrane defect or an insufficiently wetted filter.
PassBubble point ≥ manufacturer minimum — membrane integrity confirmed, filter released for use
FailBubble point below minimum — filter must be replaced before compressed air supply is used in GMP process
Method B — Preferred for Production
Forward Flow Diffusion Test
ASTM F316 · USP <1229.3> · Automated instrument preferred
The forward flow diffusion test applies a steady gas pressure at 80% of the rated bubble point to the upstream side of the wetted membrane and measures the rate of gas flow that diffuses through the membrane to the downstream side. At sub-bubble-point pressure, gas flow through an intact membrane occurs only by dissolution of gas molecules into the wetting fluid and diffusion through — a quantitative, predictable rate.
Why forward flow is preferred for production use: Unlike the bubble point test, the forward flow test can be performed with fully automated integrity test instruments that produce a printed result certificate, do not require operator judgment of bubble appearance, and are validated by installation qualification as part of the compressed air system. Automated testing eliminates operator variability and provides traceability for each test result in your GMP documentation system.
PassMeasured flow rate ≤ maximum specified for that membrane — integrity confirmed, filter released
FailFlow rate exceeds limit — indicates membrane damage, wetting failure or bypass leak — investigate and replace
Microbial Monitoring of Pharmaceutical Compressed Air — Sampling Frequency & Action Limits
EU GMP Annex 1 and site-specific Contamination Control Strategies (CCS) require periodic microbial monitoring of compressed air at each point of use in pharmaceutical manufacturing areas. The monitoring programme must define sampling methods, sampling frequency, alert limits and action limits — with documented responses to exceedances. Microbial monitoring does not replace sterile filter integrity testing: both are required for compressed air used in sterile pharmaceutical manufacturing.
| Area / Application | GMP Classification | Sampling Method | Frequency | Alert Limit | Action Limit | Regulatory Basis |
|---|---|---|---|---|---|---|
| Aseptic Filling — Direct Air | Grade A (at rest & in operation) | Impaction sampler — 1,000 L per sample | Each filling campaign | <1 CFU/m³ | 1 CFU/m³ | EU GMP Annex 1 §9.13 |
| Isolator / RABS Air Supply | Grade A equivalent (ISO Class 5) | Impaction — post 0.2 µm filter | Each batch cycle | <1 CFU/m³ | 1 CFU/m³ | EU GMP Annex 1 §8.18–8.22 |
| Lyophilizer Chamber Vent | Grade A environment contact | Impaction — after sterile vent filter | Each lyophilization cycle | <1 CFU/m³ | 1 CFU/m³ | EU GMP Annex 1 §8.86 |
| Grade B Background Cleanroom | Grade B (ISO Class 7) | Impaction sampler — 500 L per sample | Weekly minimum | 5 CFU/m³ | 10 CFU/m³ | EU GMP Annex 1 §9.13 |
| Grade C/D Manufacturing | Grade C (ISO Class 8) | Impaction or settle plate equivalent | Monthly minimum | 50 CFU/m³ | 100 CFU/m³ | EU GMP Annex 1 §9.13; site CCS |
| Tablet Coating — Direct Contact | Controlled non-classified (CNC) | Impaction — at atomisation nozzle | Quarterly per validated schedule | Site-specific | Site-specific | EU GMP Part I Ch.5; site CCS |
| API Synthesis — Aeration Air | Per ICH Q7 product risk assessment | Per validated product-specific method | Per validated programme | Product spec | Product spec | ICH Q7 §4.5; EU GMP Part II |
Standards & Compliance
ISO 8573-1 Class 0 EU GMP Annex 1 USP <1229.3> USP <1116> ASTM F316 FDA 21 CFR Part 211 ICH Q7 PIC/S PE-009
Specify Your Pharmaceutical Compressed Air Filtration System
Our pharmaceutical filtration engineers design complete multi-stage compressed air filtration systems for pharmaceutical manufacturers throughout Thailand. From ISO 8573-1 filtration stage specification and filter housing selection to integrity testing programs, IQ/OQ qualification support, and ongoing filter management, we deliver reliable filtration solutions for regulated pharmaceutical production environments.
Get expert guidance when you need it. Our support team is here to provide you with the right solutions.
